These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation. Al Shekaili L; Sheikh F; Al Gazlan S; Al Dhekri H; Al Mousa H; Al Ghonaium A; Al Saud B; Al Mohsen S; Rehan Khaliq AM; Al Sumayli S; Al Zahrani M; Dababo A; AlKawi A; Hawwari A; Arnaout R Clin Immunol; 2017 May; 178():39-44. PubMed ID: 27890707 [TBL] [Abstract][Full Text] [Related]
5. [Severe atopy and allergy--rare hyper-IgE syndrome caused by the DOCK8 mutation as underlying condition]. Koskenvuo M; Kainulainen L; Vanto T; Lukkarinen H; Lähteenmäki P; Ruuskanen O Duodecim; 2015; 131(6):541-4. PubMed ID: 26237897 [TBL] [Abstract][Full Text] [Related]
6. The clinical and laboratory spectrum of dedicator of cytokinesis 8 immunodeficiency syndrome in patients with a unique mutation. Broides A; Mandola AB; Levy J; Yerushalmi B; Pinsk V; Eldan M; Shubinsky G; Hadad N; Levy R; Nahum A; Ben-Harosh M; Lev A; Simon A; Somech R Immunol Res; 2017 Jun; 65(3):651-657. PubMed ID: 28070732 [TBL] [Abstract][Full Text] [Related]
7. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review. Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791 [TBL] [Abstract][Full Text] [Related]
8. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients. Alsum Z; Hawwari A; Alsmadi O; Al-Hissi S; Borrero E; Abu-Staiteh A; Khalak HG; Wakil S; Eldali AM; Arnaout R; Al-Ghonaium A; Al-Muhsen S; Al-Dhekri H; Al-Saud B; Al-Mousa H J Clin Immunol; 2013 Jan; 33(1):55-67. PubMed ID: 22968740 [TBL] [Abstract][Full Text] [Related]
9. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Bittner TC; Pannicke U; Renner ED; Notheis G; Hoffmann F; Belohradsky BH; Wintergerst U; Hauser M; Klein B; Schwarz K; Schmid I; Albert MH Klin Padiatr; 2010 Nov; 222(6):351-5. PubMed ID: 21058221 [TBL] [Abstract][Full Text] [Related]
10. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis. Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous manifestations of DOCK8 deficiency syndrome. Chu EY; Freeman AF; Jing H; Cowen EW; Davis J; Su HC; Holland SM; Turner ML Arch Dermatol; 2012 Jan; 148(1):79-84. PubMed ID: 21931011 [TBL] [Abstract][Full Text] [Related]
12. Lineage-Specific Chimerism and Outcome After Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency. Raedler J; Magg T; Rohlfs M; Klein C; Vallée T; Hauck F; Albert MH J Clin Immunol; 2021 Oct; 41(7):1536-1548. PubMed ID: 34080085 [TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations of hyper IgE syndromes. Freeman AF; Holland SM Dis Markers; 2010; 29(3-4):123-30. PubMed ID: 21178271 [TBL] [Abstract][Full Text] [Related]